PROWESS: (PROstate Cancer Wearables, Exercise, and Structured Supports)
Jamie Jacobs, PhD, presents a talk on the PROWESS study for Black and Latino men with metastatic prostate cancer undergoing ADT.
Read MoreSelect Page
Jamie Jacobs, PhD, is the program director for the Center for Psychiatric Oncology & Behavioral Sciences at Massachusetts General Hospital (MGH) Cancer Center in Boston, Massachusetts. She is a clinical researcher and the director of the Caregiving Research Program in the MGH Cancer Outcomes Research & Education Program (CORE). She is also an associate professor of Psychology in the Department of Psychiatry at Harvard Medical School.
Dr. Jacobs received her PhD in health psychology and behavioral medicine from the University of Miami, Florida. She then completed a post-baccalaureate research fellowship at the National Institutes of Health and pre-doctoral and post-doctoral fellowships at Massachusetts General Hospital.
Research interests emphasize coping with cancer diagnosis and treatment, and evidence-based interventions to improve physical and emotional outcomes and symptom management for cancer patients, cancer survivors, and cancer caregivers. She is also interested in stress-related physiological processes (e.g., immunologic, neuroendocrine, inflammation, and gene expression). Dr. Jacobs has presented her research findings related to mood, stress, and biopsychosocial processes in cancer at national and international scientific meetings. She has over 40 published works, including peer-reviewed publications and book chapters, has acted as principal investigator and co-investigator of funded grants from the National Cancer Institute of the National Institutes of Health, and serves as an ad-hoc reviewer for peer-reviewed journals such as JAMA Oncology, the Journal of Clinical Oncology, Psycho-Oncology, Cancer, and Annals of Behavioral Medicine.
Posted by Jamie Jacobs, PhD | Mar 2025
Jamie Jacobs, PhD, presents a talk on the PROWESS study for Black and Latino men with metastatic prostate cancer undergoing ADT.
Read More